vs
CUMBERLAND PHARMACEUTICALS INC（CPIX）与FIDELITY D & D BANCORP INC（FDBC）财务数据对比。点击上方公司名可切换其他公司
FIDELITY D & D BANCORP INC的季度营收约是CUMBERLAND PHARMACEUTICALS INC的1.8倍（$24.4M vs $13.7M），FIDELITY D & D BANCORP INC净利率更高（32.5% vs -10.3%，领先42.9%），CUMBERLAND PHARMACEUTICALS INC同比增速更快（31.1% vs 15.0%），FIDELITY D & D BANCORP INC自由现金流更多（$24.8M vs $3.0K），过去两年CUMBERLAND PHARMACEUTICALS INC的营收复合增速更高（26.9% vs 11.8%）
坎伯兰制药是一家专科制药企业，专注于开发、生产和商业化品牌处方药物，核心产品覆盖急症护理、胃肠病、疼痛管理及罕见病治疗领域，主要运营市场为美国，为相关医护人员与患者提供服务。
Fidelity D & D Bancorp Inc是一家总部位于美国的地区性银行控股公司，主要在宾夕法尼亚州东北部开展业务，为个人消费者、小微企业及当地社区客户提供存款账户、消费及商业贷款、抵押贷款、财富管理等综合零售及商业银行服务。
CPIX vs FDBC — 直观对比
营收规模更大
FDBC
是对方的1.8倍
$13.7M
营收增速更快
CPIX
高出16.1%
15.0%
净利率更高
FDBC
高出42.9%
-10.3%
自由现金流更多
FDBC
多$24.8M
$3.0K
两年增速更快
CPIX
近两年复合增速
11.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.7M | $24.4M |
| 净利润 | $-1.4M | $7.9M |
| 毛利率 | 83.6% | — |
| 营业利润率 | -10.0% | 37.7% |
| 净利率 | -10.3% | 32.5% |
| 营收同比 | 31.1% | 15.0% |
| 净利润同比 | 25.8% | 36.1% |
| 每股收益（稀释后） | $-0.09 | $1.29 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CPIXFDBC
| Q4 25 | $13.7M | $24.4M | ||
| Q3 25 | $8.3M | $23.5M | ||
| Q2 25 | $10.8M | $23.3M | ||
| Q1 25 | $11.7M | $22.0M | ||
| Q4 24 | $10.4M | $21.2M | ||
| Q3 24 | $9.1M | $20.4M | ||
| Q2 24 | $9.8M | $19.7M | ||
| Q1 24 | $8.5M | $19.5M |
净利润CPIXFDBC
| Q4 25 | $-1.4M | $7.9M | ||
| Q3 25 | $-1.9M | $7.3M | ||
| Q2 25 | $-740.7K | $6.9M | ||
| Q1 25 | $1.3M | $6.0M | ||
| Q4 24 | $-1.9M | $5.8M | ||
| Q3 24 | $-1.5M | $5.0M | ||
| Q2 24 | $-1.1M | $4.9M | ||
| Q1 24 | $-1.9M | $5.1M |
毛利率CPIXFDBC
| Q4 25 | 83.6% | — | ||
| Q3 25 | 88.1% | — | ||
| Q2 25 | 81.4% | — | ||
| Q1 25 | 87.8% | — | ||
| Q4 24 | 81.1% | — | ||
| Q3 24 | 85.4% | — | ||
| Q2 24 | 82.6% | — | ||
| Q1 24 | 81.5% | — |
营业利润率CPIXFDBC
| Q4 25 | -10.0% | 37.7% | ||
| Q3 25 | -23.7% | 36.5% | ||
| Q2 25 | -6.9% | 35.5% | ||
| Q1 25 | 11.0% | 32.2% | ||
| Q4 24 | -17.7% | 31.4% | ||
| Q3 24 | -18.6% | 28.2% | ||
| Q2 24 | -10.4% | 28.9% | ||
| Q1 24 | -22.0% | 29.5% |
净利率CPIXFDBC
| Q4 25 | -10.3% | 32.5% | ||
| Q3 25 | -23.4% | 31.2% | ||
| Q2 25 | -6.8% | 29.7% | ||
| Q1 25 | 10.7% | 27.2% | ||
| Q4 24 | -18.2% | 27.5% | ||
| Q3 24 | -17.0% | 24.3% | ||
| Q2 24 | -11.0% | 25.0% | ||
| Q1 24 | -22.9% | 25.9% |
每股收益（稀释后）CPIXFDBC
| Q4 25 | $-0.09 | $1.29 | ||
| Q3 25 | $-0.13 | $1.27 | ||
| Q2 25 | $-0.05 | $1.27 | ||
| Q1 25 | $0.08 | $1.03 | ||
| Q4 24 | $-0.13 | $1.00 | ||
| Q3 24 | $-0.11 | $0.86 | ||
| Q2 24 | $-0.08 | $0.86 | ||
| Q1 24 | $-0.14 | $0.88 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $11.4M | $148.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $24.9M | $238.9M |
| 总资产 | $76.8M | $2.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CPIXFDBC
| Q4 25 | $11.4M | $148.1M | ||
| Q3 25 | $15.2M | $142.2M | ||
| Q2 25 | $16.1M | $165.5M | ||
| Q1 25 | $15.1M | $211.2M | ||
| Q4 24 | $18.0M | $83.4M | ||
| Q3 24 | $17.5M | $120.2M | ||
| Q2 24 | $17.3M | $78.1M | ||
| Q1 24 | $18.5M | $72.7M |
股东权益CPIXFDBC
| Q4 25 | $24.9M | $238.9M | ||
| Q3 25 | $26.1M | $229.2M | ||
| Q2 25 | $28.0M | $217.9M | ||
| Q1 25 | $28.7M | $211.7M | ||
| Q4 24 | $22.9M | $204.0M | ||
| Q3 24 | $24.8M | $207.3M | ||
| Q2 24 | $26.3M | $195.7M | ||
| Q1 24 | $27.5M | $191.6M |
总资产CPIXFDBC
| Q4 25 | $76.8M | $2.7B | ||
| Q3 25 | $65.9M | $2.7B | ||
| Q2 25 | $67.9M | $2.7B | ||
| Q1 25 | $69.9M | $2.7B | ||
| Q4 24 | $75.6M | $2.6B | ||
| Q3 24 | $76.7M | $2.6B | ||
| Q2 24 | $78.5M | $2.5B | ||
| Q1 24 | $81.5M | $2.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.0K | $42.4M |
| 自由现金流经营现金流 - 资本支出 | $3.0K | $24.8M |
| 自由现金流率自由现金流/营收 | 0.0% | 101.7% |
| 资本支出强度资本支出/营收 | 0.0% | 71.9% |
| 现金转化率经营现金流/净利润 | — | 5.34× |
| 过去12个月自由现金流最近4个季度 | $4.8M | $45.4M |
8季度趋势，按日历期对齐
经营现金流CPIXFDBC
| Q4 25 | $3.0K | $42.4M | ||
| Q3 25 | $187.2K | $8.4M | ||
| Q2 25 | $843.8K | $12.6M | ||
| Q1 25 | $3.9M | $11.7M | ||
| Q4 24 | $1.9M | $29.6M | ||
| Q3 24 | $475.5K | $9.1M | ||
| Q2 24 | $-855.7K | $8.7M | ||
| Q1 24 | $-2.1M | $5.3M |
自由现金流CPIXFDBC
| Q4 25 | $3.0K | $24.8M | ||
| Q3 25 | $163.4K | $2.2M | ||
| Q2 25 | $817.3K | $6.9M | ||
| Q1 25 | $3.9M | $11.5M | ||
| Q4 24 | $1.9M | $24.9M | ||
| Q3 24 | $460.1K | $7.8M | ||
| Q2 24 | $-862.8K | $7.2M | ||
| Q1 24 | $-2.2M | $4.0M |
自由现金流率CPIXFDBC
| Q4 25 | 0.0% | 101.7% | ||
| Q3 25 | 2.0% | 9.3% | ||
| Q2 25 | 7.5% | 29.6% | ||
| Q1 25 | 32.9% | 52.3% | ||
| Q4 24 | 18.2% | 117.3% | ||
| Q3 24 | 5.1% | 38.1% | ||
| Q2 24 | -8.8% | 36.6% | ||
| Q1 24 | -25.6% | 20.7% |
资本支出强度CPIXFDBC
| Q4 25 | 0.0% | 71.9% | ||
| Q3 25 | 0.3% | 26.5% | ||
| Q2 25 | 0.2% | 24.4% | ||
| Q1 25 | 0.4% | 0.8% | ||
| Q4 24 | 0.0% | 22.0% | ||
| Q3 24 | 0.2% | 6.3% | ||
| Q2 24 | 0.1% | 7.5% | ||
| Q1 24 | 0.5% | 6.7% |
现金转化率CPIXFDBC
| Q4 25 | — | 5.34× | ||
| Q3 25 | — | 1.15× | ||
| Q2 25 | — | 1.82× | ||
| Q1 25 | 3.10× | 1.95× | ||
| Q4 24 | — | 5.07× | ||
| Q3 24 | — | 1.83× | ||
| Q2 24 | — | 1.76× | ||
| Q1 24 | — | 1.05× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
